This Article Abstract Full Text Full Text (PDF) View Supplemental Tables Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Costello-Boerrigter, L. C. Articles by Burnett, J. C. Search for Related Content PubMed PubMed Citation Articles by Costello-Boerrigter, L. C. Articles by Burnett, J. C., Jr

Amino-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide in the General Community

Determinants and Detection of Left Ventricular Dysfunction

Lisa C. Costello-Boerrigter, MD, PhD^_*,,_*, Guido Boerrigter, MD^_*, Margaret M. Redfield, MD^_*,, Richard J. Rodeheffer, MD, Lynn H. Urban, MS, Douglas W. Mahoney, MS, Steven J. Jacobsen, MD, PhD, Denise M. Heublein, CLT^_* and John C. Burnett, Jr, MD^_*,

^_* Cardiorenal Research Laboratory
Division of Cardiovascular Diseases
Division of Biostatistics
Division of Epidemiology, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minnesota

View larger version (28K): [in a new window]   Figure 1 The receiver operating characteristic (ROC) curves of amino-terminal pro-B-type natriuretic peptide (NT-proBNP) (red) and BNP (green) for detecting an ejection fraction (EF) 40% for the entire population (all) (A), patients 65 years old (B), male patients (C), and female patients (D).